Trials / Conditions / Relapsed Ewing Sarcoma
Relapsed Ewing Sarcoma
5 registered clinical trials studyying Relapsed Ewing Sarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sa NCT05734066 | Jazz Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Cabozantinib With Topotecan-Cyclophosphamide NCT04661852 | Dana-Farber Cancer Institute | Phase 1 |
| Active Not Recruiting | C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL NCT03635632 | Baylor College of Medicine | Phase 1 |
| Terminated | A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma NCT03514407 | Incyte Corporation | Phase 1 |
| Completed | Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma NCT02546544 | University of Oxford | Phase 2 |